Utilizing cannabis for MS management: a new webinar series from CMSC & NeurologyLive®

WellnessLeave a comment

The Consortium of Multiple Sclerosis Centers (CMSC), the largest North American multidisciplinary membership organization dedicated to defining and advancing the standard of care of MS patients, announces a new webinar series: Utilizing Cannabis for MS Management: Helping Patients Understand Risks and Benefits. This 3-part educational program is being produced in partnership with NeurologyLive®, a multimedia…

Details

HSE University researcher develops global HIV prevention index for drug users

WellnessLeave a comment

Peter Meylakhs, from HSE University – St. Petersburg, together with colleagues from Georgia State University (USA) and Tarbiat Modares University (Tehran), have developed the HIV-PWID Policy Index (HPPI)–an international policy index for HIV prevention among people who inject drugs. This is the first major tool for assessing and comparing the extent to which HIV/AIDS prevention…

Details

Female surgeons perform less complex cases than male peers, likely due to systemic bias

WellnessLeave a comment

BOSTON – Female surgeons at a large academic medical center perform less complex surgical procedures than their male counterparts, according to a new study by researchers at Massachusetts General Hospital (MGH). This study, published in Annals of Surgery, is one of the first to measure the problem of underemployment among female surgeons in the United…

Details

More evidence of benefits of REGN-COV2 antibody cocktail to both protect from and treat disease

WellnessLeave a comment

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging. Now, expanding upon this work, researchers show this antibody cocktail offers benefits in animal models…

Details

Antibodies from patients infected with SARS-CoV in 2003 cross-neutralized SARS-CoV-2 in vitro

WellnessLeave a comment

Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study. The authors also report that, surprisingly, mice and rabbits immunized with a receptor binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger…

Details